Grandeur Peak Global Advisors LLC Takes Position in Bruker Co. (NASDAQ:BRKR)

Grandeur Peak Global Advisors LLC acquired a new stake in Bruker Co. (NASDAQ:BRKR - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 40,404 shares of the medical research company's stock, valued at approximately $2,368,000.

Several other hedge funds have also added to or reduced their stakes in the business. Retirement Systems of Alabama grew its position in shares of Bruker by 11.7% in the 3rd quarter. Retirement Systems of Alabama now owns 134,254 shares of the medical research company's stock valued at $9,272,000 after purchasing an additional 14,069 shares during the period. Merit Financial Group LLC bought a new position in Bruker during the 4th quarter worth about $300,000. Bank of New York Mellon Corp raised its stake in shares of Bruker by 7.6% in the 4th quarter. Bank of New York Mellon Corp now owns 988,863 shares of the medical research company's stock valued at $57,967,000 after purchasing an additional 69,806 shares during the period. Blue Trust Inc. boosted its position in shares of Bruker by 13.5% during the fourth quarter. Blue Trust Inc. now owns 2,164 shares of the medical research company's stock worth $127,000 after buying an additional 257 shares during the period. Finally, Allspring Global Investments Holdings LLC raised its position in Bruker by 1.8% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 214,580 shares of the medical research company's stock valued at $12,619,000 after buying an additional 3,819 shares during the last quarter. Institutional investors and hedge funds own 79.52% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Citigroup cut their price objective on shares of Bruker from $75.00 to $50.00 and set a "buy" rating on the stock in a research report on Monday, April 7th. Barclays lowered their target price on Bruker from $60.00 to $50.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. Guggenheim reiterated a "buy" rating on shares of Bruker in a report on Monday, February 24th. Finally, Stifel Nicolaus lowered their price target on Bruker from $70.00 to $57.00 and set a "hold" rating on the stock in a research report on Friday, February 14th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $66.50.

Remove Ads

Bruker Stock Performance

BRKR traded down $1.54 during trading on Tuesday, hitting $38.43. The stock had a trading volume of 1,974,902 shares, compared to its average volume of 1,484,776. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.60 and a quick ratio of 0.77. The firm has a market cap of $5.83 billion, a price-to-earnings ratio of 50.57, a P/E/G ratio of 2.16 and a beta of 1.18. The company has a 50 day moving average price of $45.46 and a 200-day moving average price of $54.31. Bruker Co. has a one year low of $34.10 and a one year high of $85.82.

Bruker (NASDAQ:BRKR - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. As a group, research analysts predict that Bruker Co. will post 2.69 EPS for the current year.

Bruker Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 28th. Investors of record on Monday, March 17th were issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.52%. The ex-dividend date of this dividend was Monday, March 17th. Bruker's dividend payout ratio (DPR) is presently 26.32%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.